Meine Zukunft Innovative Chemie Interviews Inspirierende Job-Links Meine Ausbildung

Biomay AG

Biomay Logo

The Biomay Produktions- und Handels- Aktiengesellschaft, founded 17 years ago by Mag. Mayrhofer, today claims an important place among the young gene technology companies which are at the forefront of research in the pharmaceutical industry, thereby providing effective treatment possibilities for various diseases. Biomay specializes in the development and production of allergenes which are "recombinant", i.e. produced by using gene technology.

News Focussing on Members

(AVIR Green Hills Biotechnology AG) deltaFLU –innovative vaccines for intranasal spray delivery or oral administration more 

 

(Apeptico) APEPTICO Announces Successful Completion of Phase I Trial with AP301 in Oedematous Respiratory Failure  more 

 

(Intercell) Intercell announces new management structure more 

 

(Eucodis) EUCODIS Bioscience and evocatal enter into alliance more 

 

(Intercell) Staph Bakali new Chief Business Officer more 

 

(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases more 

 

(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 more